In this paper, a dual-throat supersonic separation device with porous wall has been proposed to solve the starting problem of supersonic separator, and the feasibility of the proposed device has been tested numericall...In this paper, a dual-throat supersonic separation device with porous wall has been proposed to solve the starting problem of supersonic separator, and the feasibility of the proposed device has been tested numerically and experimentally. Its flow characteristics have been investigated and the effect of some important parameters includ-ing nozzle pressure ratio(RNP), inlet temperature and swirl intensity were examined. In the device, the supersonic flow state and strong centrifugal acceleration of 240000g can be obtained, which are necessary for the condensation and separation of water vapor. The supersonic region in the device enlarged and the shock wave shifted downstream along with the increasing RNP. The separation performance was improved with the increasing RNP and the inlet temperature. The best separation performance in this study was obtained with ΔTd? 28 K.展开更多
Irbesartan is an antihypertensive drug whose concentration in blood is very small so it requires a sensitive method of analysis, selective and valid for analysis. In this study, it is carried out optimization of analy...Irbesartan is an antihypertensive drug whose concentration in blood is very small so it requires a sensitive method of analysis, selective and valid for analysis. In this study, it is carried out optimization of analytical conditions and validation for the analysis of irbesartan in plasma. Chromatography was performed on a C 18 column （250 × 4.6 mm, 5 μm） under isocratic elution with acetonitrile-0.1% formic acid （46：54 v/v）, pH 3.75. Detection was made at excitation 250 nm and emission 370 nm and analyses were run at a flow-rate of 1.0 mL/min at a temperature of 40 ℃. Losartan potassium was used as internal standard. Plasma extraction was done by deproteination with acetonitrile, mixed with vortex for 30 seconds, then centrifuged it at 10,000 rpm for 10 rain. In plasma validation, the recovery was 96.22%, and the lower limit of quantification （LLOQ） in plasma was 2 ng/mL. The method also fulfill the criteria for accuracy and precision intra and inter day by normal values （%Diff） not exceed ± 15%. On the stability study, irbesartan in plasma temperature -20 ℃has been stable for 28 days.展开更多
文摘In this paper, a dual-throat supersonic separation device with porous wall has been proposed to solve the starting problem of supersonic separator, and the feasibility of the proposed device has been tested numerically and experimentally. Its flow characteristics have been investigated and the effect of some important parameters includ-ing nozzle pressure ratio(RNP), inlet temperature and swirl intensity were examined. In the device, the supersonic flow state and strong centrifugal acceleration of 240000g can be obtained, which are necessary for the condensation and separation of water vapor. The supersonic region in the device enlarged and the shock wave shifted downstream along with the increasing RNP. The separation performance was improved with the increasing RNP and the inlet temperature. The best separation performance in this study was obtained with ΔTd? 28 K.
文摘Irbesartan is an antihypertensive drug whose concentration in blood is very small so it requires a sensitive method of analysis, selective and valid for analysis. In this study, it is carried out optimization of analytical conditions and validation for the analysis of irbesartan in plasma. Chromatography was performed on a C 18 column （250 × 4.6 mm, 5 μm） under isocratic elution with acetonitrile-0.1% formic acid （46：54 v/v）, pH 3.75. Detection was made at excitation 250 nm and emission 370 nm and analyses were run at a flow-rate of 1.0 mL/min at a temperature of 40 ℃. Losartan potassium was used as internal standard. Plasma extraction was done by deproteination with acetonitrile, mixed with vortex for 30 seconds, then centrifuged it at 10,000 rpm for 10 rain. In plasma validation, the recovery was 96.22%, and the lower limit of quantification （LLOQ） in plasma was 2 ng/mL. The method also fulfill the criteria for accuracy and precision intra and inter day by normal values （%Diff） not exceed ± 15%. On the stability study, irbesartan in plasma temperature -20 ℃has been stable for 28 days.
